An analysis of 117 cancer drugs approved by the US FDA over a 20-year period finds the drugs took a median of 6.5 years to go from the first clinical trial in adults to the first trial in children. ‘As a doctor taking care of young cancer patients, this is tremendously frustrating,’ says lead researcher Steven DuBois, M.D. ‘If I were a parent of a child with cancer, I wouldn’t stand for this.’
Source: EurekaAlert, https://www.eurekalert.org